Not applicableStudy completedNCT02190578What this trial is testingClinical Performance of Reveal G4 Rapid HIV-1 Antibody TestWho this might be right forHIV Infections MedMira Laboratories Inc. 1,649
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07675629What this trial is testingEvaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected AdultsWho this might be right forHIV Prevention Worcester HIV Vaccine 126
Early research (Phase 1)Study completedNCT04985760What this trial is testingEvaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral TherapyWho this might be right forHIV Infections Madhu Chhanda Choudhary 32
Early research (Phase 1)Study completedNCT02256631What this trial is testingEvaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed InfantsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 83
Early research (Phase 1)Looking for participantsNCT07392372What this trial is testingA Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIVWho this might be right forHIV -1 Infection BioNTech SE 67
Early research (Phase 1)Study completedNCT02658968What this trial is testingStudy of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)Who this might be right forRelapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma Nordic Nanovector 18
Not applicableStudy completedNCT01859195What this trial is testingMonoclonal Antibody-based Multipurpose MicrobicidesWho this might be right forHIVSexually Transmitted Infections (STI) The Miriam Hospital 36
Testing effectiveness (Phase 2)Study completedNCT05281510What this trial is testingStudy of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected WomenWho this might be right forHIV-1-infection Gilead Sciences 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06508749What this trial is testingThe Tatelo Plus StudyWho this might be right forHIVHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 41
Large-scale testing (Phase 3)Ended earlyNCT01288131What this trial is testingStudy of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) TreatmentWho this might be right forAnti-r-HuEpo Associated PRCA Subjects Chulalongkorn University 8
Early research (Phase 1)Study completedNCT00000886What this trial is testingA Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)WithdrawnNCT01443117What this trial is testingEvaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant WomenWho this might be right forPneumococcal InfectionsHIV Infections National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00784147What this trial is testingDose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1Who this might be right forHIV TaiMed Biologics Inc. 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT07215468What this trial is testingHIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies StudyWho this might be right forHIV -1 Infection TaiMed Biologics Inc. 88
Early research (Phase 1)Study completedNCT03015181What this trial is testingVRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy AdultsWho this might be right forHIV Prevention National Institute of Allergy and Infectious Diseases (NIAID) 26
Testing effectiveness (Phase 2)Study completedNCT01707472What this trial is testingStudy of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver FibrosisWho this might be right forLiver FibrosisHepatitis CHIV+1 more Gilead Sciences 18
Not applicableStudy completedNCT01447680What this trial is testingComparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody TestingWho this might be right forHuman Immunodeficiency Virus InfectionHepatitis C G & W Laboratories Inc. 1,600
Early research (Phase 1)Study completedNCT02579083What this trial is testingSafety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIVWho this might be right forHIVHerpes Simplex Infections KBio Inc 38
Testing effectiveness (Phase 2)Study completedNCT00055237What this trial is testingBevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative PatientsWho this might be right forKaposi's SarcomaHIV InfectionsHIV Seronegativity National Cancer Institute (NCI) 19
Not applicableStudy completedNCT04033887What this trial is testingEvaluation Study of RDTs Detecting Antibodies Against HCVWho this might be right forHepatitis C Foundation for Innovative New Diagnostics, Switzerland 1,710